(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
4 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 6.60%
3.11% $ 8.95
Live Chart Being Loaded With Signals
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug...
Stats | |
---|---|
Volumen de hoy | 26 194.00 |
Volumen promedio | 45 775.00 |
Capitalización de mercado | 215.00M |
EPS | $0.400 ( 2024-03-15 ) |
Próxima fecha de ganancias | ( $0.193 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 8.14 |
ATR14 | $0.0460 (0.51%) |
Cipher Pharmaceuticals Correlación
10 Correlaciones Más Positivas | |
---|---|
ATD.TO | 0.901 |
RQL.TO | 0.886 |
CCO.TO | 0.87 |
BDT.TO | 0.865 |
PKI.TO | 0.863 |
BDI.TO | 0.863 |
RQN.TO | 0.857 |
CMG.TO | 0.857 |
SNC.TO | 0.837 |
THNC.TO | 0.832 |
10 Correlaciones Más Negativas | |
---|---|
HOT-UN.TO | -0.899 |
GEO.TO | -0.858 |
LGO.TO | -0.857 |
WEF.TO | -0.852 |
PLRB.V | -0.852 |
HEXO.TO | -0.838 |
BYL.TO | -0.835 |
CRRX.TO | -0.831 |
FIL.TO | -0.831 |
S.TO | -0.827 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cipher Pharmaceuticals Finanzas
Annual | 2023 |
Ingresos: | $21.16M |
Beneficio Bruto: | $17.09M (80.77 %) |
EPS: | $0.820 |
FY | 2023 |
Ingresos: | $21.16M |
Beneficio Bruto: | $17.09M (80.77 %) |
EPS: | $0.820 |
FY | 2022 |
Ingresos: | $20.68M |
Beneficio Bruto: | $16.68M (80.69 %) |
EPS: | $0.250 |
FY | 2021 |
Ingresos: | $21.94M |
Beneficio Bruto: | $18.26M (83.21 %) |
EPS: | $0.0740 |
Financial Reports:
No articles found.
Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico